Groove Botanicals (GRVE) EBIAT (2016 - 2025)
Groove Botanicals' EBIAT history spans 8 years, with the latest figure at -$58255.0 for Q1 2017.
- On a quarterly basis, EBIAT rose 97.57% to -$58255.0 in Q1 2017 year-over-year; TTM through Mar 2017 was -$243193.0, a 90.29% increase, with the full-year FY2025 number at -$130834.0, up 35.26% from a year prior.
- EBIAT hit -$58255.0 in Q1 2017 for Groove Botanicals, up from -$124294.0 in the prior quarter.
- Over the last five years, EBIAT for GRVE hit a ceiling of $209329.0 in Q1 2015 and a floor of -$2.4 million in Q1 2016.
- Historically, EBIAT has averaged -$220952.2 across 5 years, with a median of -$120125.0 in 2015.
- Biggest five-year swings in EBIAT: soared 235.41% in 2015 and later tumbled 1243.36% in 2016.
- Tracing GRVE's EBIAT over 5 years: stood at -$158601.0 in 2013, then skyrocketed by 169.34% to $109977.0 in 2014, then crashed by 217.65% to -$129385.0 in 2015, then grew by 3.93% to -$124294.0 in 2016, then skyrocketed by 53.13% to -$58255.0 in 2017.
- Business Quant data shows EBIAT for GRVE at -$58255.0 in Q1 2017, -$124294.0 in Q4 2016, and -$28369.0 in Q3 2016.